免疫相关性和TIL疗法的机制:当前的见解和知识差距
Blanca Navarro Rodrigo1, Yaquelin Ortiz Miranda2, Jesús Corria-Osorio2
1Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
Trends in cancer
|August 30, 2025
概括
瘤透性淋巴细胞 (TIL) 疗法在癌症治疗中表现有前途,特别是在最近获得FDA对黑色素瘤的批准后. 了解TIL和瘤微环境 (TME) 的进展为在固体瘤中更广泛的应用铺平了道路.
科学领域:
- 免疫学
- 癌症学
- 癌症免疫疗法
背景情况:
- 瘤透淋巴细胞 (TIL) 治疗是癌症治疗的一个快速发展领域.
- 美国食品和药物管理局最近批准使用lifileucel治疗晚期黑色素瘤是一个重要的里程碑.
- 了解TIL治疗的免疫机制对于其优化至关重要.
研究的目的:
- 综合有关TIL疗法的免疫相关物和机制的当前知识.
- 突出瘤免疫性,TIL功能状态和瘤微环境 (TME) 的作用.
- 讨论TIL治疗的最新进展和未来发展方向.
主要方法:
- 对TIL治疗的当前科学文献的综述.
- 在TIL治疗中分析单细胞分析数据和生物标志物的发现.
- 审查新的TIL扩展协议和工程策略.
主要成果:
- 治疗TIL的有效性与瘤免疫性,TIL功能状态和TME有关.
- 单细胞分析和生物标志物有助于患者选择和治疗优化.
- 新的方法正在扩大TIL治疗的适用于各种固体癌症.
结论:
- 下一代TIL疗法对癌症治疗具有重大前景.
- 进一步研究TIL机制和TME相互作用是必不可少的.
- 在更广泛的固体瘤中,TIL疗法将成为关键疗法.
相关概念视频
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Cell-mediated Immune Responses
72.2K
Overview
72.2K
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


